Hospital-acquired pressure ulcers are a preventable condition. Familiar standard interventions include lotions, creams, or specialty beds. Yet incidence rates continue to increase.
The industry's first FDA cleared*, evidence-based** therapeutic silk-like bedding and patient apparel to help to reduce the likelihood of patients developing pressure ulcers.
As cited in the
National Pressure Ulcer Advisory Panel (NPUAP)
Clinical Practice Guideline:
Developed by the industry leader in engineered healthcare products, DermaTherapy®'s patented performance is backed by independent clinical studies.
It´s time to redefine the standard of care.
It´s time to put an end to hospital-acquired pressure ulcers.